Fig. 3
From: Recombinant pharmaceuticals from microbial cells: a 2015 update
Amount of marketed recombinant proteins (expressed in percentages) applied to each therapeutic area. Coloured in pink, other therapeutic areas (<5 % each) include diseases related to cardiology, central nervous system, ophthalmology and dermatology among others